PubRank

Franco Veglio

Author PubWeight™ 88.14‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004 2.56
2 Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension 2012 2.31
3 Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas. Hypertension 2013 1.76
4 Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. J Clin Endocrinol Metab 2009 1.53
5 Genetic polymorphism of the renin-angiotensin-aldosterone system and arterial hypertension in the Italian population: the GENIPER Project. J Hypertens 2003 1.52
6 KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism. Hypertension 2011 1.51
7 Concurrent primary aldosteronism and subclinical cortisol hypersecretion: a prospective study. J Hypertens 2011 1.50
8 Assessment of cardiac autonomic modulation during adolescent obesity. Obes Res 2003 1.45
9 Anti-hypertensive drugs and left ventricular hypertrophy: a clinical update. Intern Emerg Med 2010 1.43
10 [Assessment of cardiovascular risk in hypertensive patients: comparison among scores]. Ital Heart J Suppl 2004 1.40
11 [Hypertensive emergency and urgency: clinical update]. G Ital Cardiol (Rome) 2010 1.40
12 [Hypertensive heart disease: diagnostic and therapeutic guidelines]. G Ital Cardiol (Rome) 2008 1.39
13 Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab 2005 1.36
14 Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension 2002 1.23
15 Role of KCNJ5 in familial and sporadic primary aldosteronism. Nat Rev Endocrinol 2012 1.20
16 Diagnosis of primary aldosteronism: from screening to subtype differentiation. Trends Endocrinol Metab 2005 1.19
17 Prognostic relevance of masked hypertension in subjects with prehypertension. Am J Hypertens 2008 1.17
18 Echocardiographic indexes for the non-invasive evaluation of pulmonary hemodynamics. J Am Soc Echocardiogr 2010 1.15
19 Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab 2013 1.15
20 Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. J Clin Endocrinol Metab 2008 1.12
21 Protective effect of anti-hypertensive treatment on cognitive function in essential hypertension: analysis of published clinical data. J Neurol Sci 2002 1.07
22 Orthostatic hypotension: evaluation and treatment. Cardiovasc Hematol Disord Drug Targets 2007 1.07
23 Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism. Hypertension 2010 1.05
24 Left ventricular hypertrophy in patients with autonomic failure. Am J Hypertens 2006 1.05
25 LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms. Atherosclerosis 2009 1.01
26 Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms). Hypertension 2011 1.01
27 Hypertension and cognitive function. Clin Exp Hypertens 2008 0.99
28 Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis. Hypertension 2012 0.97
29 Similarities and differences in early retinal phenotypes in hypertension and diabetes. J Hypertens 2011 0.96
30 Prolonged QT interval and reduced heart rate variability in patients with uncomplicated essential hypertension. Hypertens Res 2008 0.95
31 Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J Clin Endocrinol Metab 2006 0.95
32 Adiponectin and insulin sensitivity in primary aldosteronism. Am J Hypertens 2007 0.94
33 Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree. J Clin Endocrinol Metab 2002 0.94
34 Teratocarcinoma-derived growth factor-1 is upregulated in aldosterone-producing adenomas and increases aldosterone secretion and inhibits apoptosis in vitro. Hypertension 2010 0.94
35 Antihypertensive drugs and the sympathetic nervous system. J Cardiovasc Pharmacol 2007 0.94
36 Arterial hypertension: a cause of cognitive impairment and of vascular dementia. Clin Exp Hypertens 2004 0.93
37 Rapid cortisol assay during adrenal vein sampling in patients with primary aldosteronism. Clin Chem 2007 0.93
38 18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes. J Clin Endocrinol Metab 2012 0.92
39 Diagnosis and treatment of low-renin hypertension. Clin Endocrinol (Oxf) 2007 0.91
40 Aldosterone inhibition in patients with heart failure with preserved ejection fraction. JAMA 2013 0.91
41 Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families. J Hypertens 2008 0.91
42 Protective effect of spironolactone on endothelial cell apoptosis. Endocrinology 2006 0.89
43 Mortality and prognosis in patients with neurogenic orthostatic hypotension. Funct Neurol 2012 0.89
44 Arterial stiffness: from physiology to clinical implications. High Blood Press Cardiovasc Prev 2011 0.87
45 Ascending aortic dilatation, arterial stiffness and cardiac organ damage in essential hypertension. J Hypertens 2013 0.87
46 Differential diagnosis of primary aldosteronism subtypes. Curr Hypertens Rep 2009 0.86
47 QT interval in patients with primary aldosteronism and low-renin essential hypertension. J Hypertens 2006 0.86
48 Liver X receptor activation reduces angiogenesis by impairing lipid raft localization and signaling of vascular endothelial growth factor receptor-2. Arterioscler Thromb Vasc Biol 2012 0.86
49 Evaluation of primary aldosteronism. Curr Opin Endocrinol Diabetes Obes 2010 0.86
50 Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis. Trends Endocrinol Metab 2008 0.85
51 A time-resolved fluoroimmunoassay for 18-oxocortisol and 18-hydroxycortisol. Development of a monoclonal antibody to 18-oxocortisol. J Steroid Biochem Mol Biol 2002 0.85
52 Circadian blood pressure patterns and life stress. Psychother Psychosom 2002 0.84
53 Bradykinin B2 receptor gene (-58T/C) polymorphism influences baroreflex sensitivity in never-treated hypertensive patients. J Hypertens 2005 0.83
54 Baroreflex sensitivity correlates with left ventricular morphology and diastolic function in essential hypertension. J Hypertens 2007 0.83
55 High-salt diet increases glomerular ACE/ACE2 ratio leading to oxidative stress and kidney damage. Nephrol Dial Transplant 2011 0.83
56 Captopril test can give misleading results in patients with suspect primary aldosteronism. Hypertension 2007 0.82
57 Early cardiovascular autonomic dysfunction, beta cell function and insulin resistance in obese adolescents. Acta Biomed 2009 0.82
58 Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism. Hypertension 2012 0.82
59 Left heart morphology and function in primary aldosteronism. High Blood Press Cardiovasc Prev 2012 0.81
60 Psychological assessment of primary aldosteronism: a controlled study. J Clin Endocrinol Metab 2011 0.81
61 Nicardipine: a hypotensive dihydropyridine-type calcium antagonist with a peculiar cerebrovascular profile. Clin Exp Hypertens 2008 0.81
62 Hypertensive retinopathy: there's more than meets the eye. J Hypertens 2005 0.81
63 Genome-wide association study identifies CAMKID variants involved in blood pressure response to losartan: the SOPHIA study. Pharmacogenomics 2014 0.81
64 Aldosterone suppression on contralateral adrenal during adrenal vein sampling does not predict blood pressure response after adrenalectomy. J Clin Endocrinol Metab 2014 0.80
65 Diagnosis and treatment of unilateral forms of primary aldosteronism. Curr Hypertens Rev 2013 0.80
66 Heart Rate Variability and Baroreflex Sensitivity during Fosinopril, Irbesartan and Atenolol Therapy in Hypertension. Clin Drug Investig 2004 0.80
67 Salt intake and hypertension therapy. J Nephrol 2002 0.79
68 Infective endocarditis after transcatheter closure of a patent foramen ovale. Catheter Cardiovasc Interv 2004 0.79
69 Diagnosis and treatment of primary aldosteronism. Rev Endocr Metab Disord 2011 0.79
70 Echocardiographic aortic root dilatation in hypertensive patients: a systematic review and meta-analysis. J Hypertens 2014 0.78
71 Cardiovascular complications in patients with autonomic failure. Clin Auton Res 2015 0.78
72 Left atrial enlargement in essential hypertension: role in the assessment of subclinical hypertensive heart disease. Blood Press 2011 0.78
73 Comparison between generalized retinal arteriolar narrowing and left ventricular mass in young untreated hypertensive patients. Blood Press 2006 0.78
74 Effectiveness of blood pressure educational and evaluation program for the improvement of measurement accuracy among nurses. High Blood Press Cardiovasc Prev 2013 0.77
75 Primary aldosteronism (PA) and endothelial progenitor cell (EPC) bioavailability. Clin Endocrinol (Oxf) 2008 0.77
76 Is familial hyperaldosteronism underdiagnosed in hypertensive children? Hypertension 2011 0.77
77 The metabolic syndrome in primary aldosteronism. Curr Hypertens Rep 2007 0.77
78 Ventricular repolarization before and after treatment in patients with secondary hypertension due to renal-artery stenosis and primary aldosteronism. Hypertens Res 2011 0.77
79 Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism. J Hypertens 2016 0.77
80 Arterial hypertension and cancer. Int J Cancer 2013 0.76
81 Hypertension, genotype and oral contraceptives. Pharmacogenomics 2002 0.76
82 Genes implicated in insulin resistance are down-regulated in primary aldosteronism patients. Mol Cell Endocrinol 2012 0.76
83 The metabolic syndrome in primary aldosteronism. Curr Diab Rep 2008 0.76
84 Effects of birth weight on spontaneous baroreflex sensitivity in adult life. Nutr Metab Cardiovasc Dis 2006 0.76
85 Aortic root dilatation in essential hypertension: prevalence according to new reference values. J Hypertens 2013 0.76
86 Mineralocorticoid receptor blockade in the protection of target organ damage. Cardiovasc Hematol Agents Med Chem 2006 0.76
87 Blood pressure in patients with primary aldosteronism is influenced by bradykinin B(2) receptor and alpha-adducin gene polymorphisms. J Clin Endocrinol Metab 2002 0.76
88 Genetics of primary aldosteronism. J Hypertens 2004 0.76
89 Role of HSD11B2 polymorphisms in essential hypertension and the diuretic response to thiazides. Kidney Int 2005 0.76
90 CYP11B2 -344T/C gene polymorphism and blood pressure in patients with acromegaly. J Clin Endocrinol Metab 2006 0.76
91 Improving echocardiographic estimation of pulmonary vascular resistance. Heart 2011 0.75
92 Letter regarding article by Hood et al, "The Spironolactone, Amiloride, Losartan, and Thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio". Circulation 2008 0.75
93 Estimation of systolic pulmonary pressure and right ventricular systolic impairment. J Card Fail 2012 0.75
94 Correction: Central Pressure Appraisal: Clinical Validation of a Subject-Specific Mathematical Model. PLoS One 2016 0.75
95 [Left ventricular diastolic function and dysfunction: a single cardiac target for various systemic diseases]. G Ital Cardiol (Rome) 2007 0.75
96 Urinary protease inhibitor Serpin B3 is higher in women and is further increased in female patients affected by aldosterone producing adenoma. Mol Biosyst 2014 0.75
97 A particular phenotype in a girl with aldosterone synthase deficiency. J Clin Endocrinol Metab 2004 0.75
98 Arrhythmic syncope in neurogenic orthostatic hypotension: two case reports. Clin Auton Res 2014 0.75
99 Non invasive evaluation of cardiac hemodynamics in end stage renal disease (ESRD). High Blood Press Cardiovasc Prev 2014 0.75
100 Bioequivalence study of nicardipine solution versus nicardipine tablets. Clin Exp Hypertens 2004 0.75
101 Accuracy of transthoracic echocardiography in the assessment of proximal aortic diameter in hypertensive patients: comparison with cardiac magnetic resonance. J Hypertens 2017 0.75
102 Appropriateness of referral to a European society of hypertension center of excellence. J Clin Hypertens (Greenwich) 2012 0.75
103 Echocardiographic abnormalities in the assessment of cardiac organ damage in never-treated hypertensive patients. Clin Exp Hypertens 2012 0.75
104 Aldosterone as an independent factor in cerebrovascular damage. Clin Exp Hypertens 2008 0.75
105 Aortic size index enlargement is associated with central hemodynamics in essential hypertension. Hypertens Res 2010 0.75
106 Renal sympathetic denervation in a previously stented renal artery. J Clin Hypertens (Greenwich) 2014 0.75
107 [Arterial hypertension and cognitive deficit]. Ann Ital Med Int 2004 0.75
108 Atypical secondary hypertension due to mid-aortic syndrome. Eur Heart J 2012 0.75
109 Silent cerebrovascular damage and its early correlates in essential hypertensive patients. Clin Exp Hypertens 2012 0.75
110 Efficacy of antihypertensive treatment based on plasma renin activity: An open label observational study. Blood Press 2010 0.75
111 Guidelines for primary aldosteronism: uptake by primary care physicians in Europe. J Hypertens 2016 0.75